Related to this topic: Leaflets | Support | Patient+ | UK Guidelines | Online Videos | News | Weblinks | Equipment | Books | Your Experience | Other resources | Refs | Glossaries
Print options:
(tip - pdf print is neatest)
Other options:
(what's this?)
Meningococcal Group C Immunisation
| This leaflet is about protecting against the bacterium (germ) called group C Neisseria meningitidis, also known as group C meningococcus. Infection with this bacterium can cause meningitis and septicaemia (serious blood infection). All people under the age of 25 should be immunised, and it is now a routine part of the childhood immunisation programme. |
What is the meningococcus?
The meningococcus is a bacterium (germ) that can cause meningitis and septicaemia (blood infection). These infections are very serious and can be fatal if not treated quickly. There are different groups (strains or types) of meningococcal bacteria.
- Groups B and C are the common strains in the UK. Most cases of bacterial meningitis in the UK are caused by Group B. Most of the rest are caused by Group C (although the number of Group C cases has fallen greatly due to immunisation introduced in 1999).
- Group A is rare in the UK, but more common in certain parts of the world. In particular, Sub-Saharan Africa and parts of Saudi Arabia.
- Groups Y and W135 are rare in the UK but group W135 has been the cause of recent outbreaks in certain parts of the world.
Infection with the meningococcus can affect anyone, but those most at risk are: children under five years (especially those under one year), and teenagers and young adults under the age of 25.
The MenC vaccine
A vaccine to protect against the Group C meningococcus was launched in 1999. This vaccine protects against Group C only, and not against Group A or B meningococcus. (See separate leaflet called 'Meningococcal Immunisation' for details of other vaccines against other groups of meningitis which are used for travellers to 'at risk' countries.)
The vaccine against the Group C meningococcus (MenC vaccine) is thought to give lifelong immunity, so booster doses later in life are not needed.
Who should be immunised?
Babies
Babies are given the MenC vaccine as part of the routine immunisation programme. Three doses (injections) of vaccine are needed for full protection. These are normally given at ages 3, 4, and 12 months. The first two doses are usually given at the same time as the routine DTP-Polio-Hib vaccine (as a separate injection). The third dose is a combined injection with the Hib vaccine.
Others
- Older children, teenagers, and young adults under the age of 25 were offered immunisation in a 'catch up' programme after the immunisation was introduced in 1999. Most are now immunised. However, if you are under 25 and have not been immunised, see your practice nurse to get immunised. Just one injection of vaccine is needed for those over the age of one year. Once all people under the age of 25 are immunised, only the routine immunisations for new babies will need to continue.
- Close contacts of people with meningitis or septicaemia caused by Group C meningococcus if they have not been previously immunised.
Are there any side-effects to the vaccine?
Most people have no side-effects. Sometimes a mild fever develops for a short time. Some babies become irritable for a short time after the injection. Slight swelling and redness at the injection site may occur. Headache and muscle aches for a short time are reported by some older children.
None of the above side-effects are serious, and they soon settle. If necessary, you can give paracetamol or ibuprofen to children to ease pain and fever following immunisation. Serious reactions are rare.
Who should not be immunised?
- Immunisation should be postponed if a child has a high fever or serious infection. Minor infections such as coughs, colds, and snuffles are no reason to postpone immunisation.
- The vaccine should not be given if there has been a severe reaction to a previous dose (which is rare). Also, it should not be given if a person is known to be allergic to any of the ingredients in the vaccine. (These include extracts of the meningococcus bacteria, diphtheria and tetanus toxoids, and certain carrier proteins. Allergy to any of these is very rare.)
- Pregnant women. The vaccine is not thought to cause any risk to pregnant women or their unborn baby. However, as with any other vaccine, it is wise to play safe and not have it if you are pregnant unless there is a high risk of developing the disease.
Are you still at risk of meningitis after the immunisation?
Yes. This vaccine has greatly reduced the number of cases of meningitis and septicaemia since it was introduced in 1999.
However, other groups of meningococcus, and other types of bacteria can still cause meningitis. Get medical help immediately if you suspect that your child, or someone you know, has meningitis or septicaemia. The earlier the treatment of meningitis or septicaemia, the better the chance of recovery and preventing complications or death. Another leaflet in this series describes the symptoms of meningitis and septicaemia.
Further information
Information on immunisation from the NHS aimed at the general public
Preventing meningitis
Web based information from the Department of Health.
Go to their website - www.dh.gov.uk and search for 'meningitis'.
References
- Department of Health - The Green Book; Immunisation Against Infectious Disease 2006
- PRODIGY Immunizations - childhood vaccination programme 2005
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicineInformation leaflets related to this topic (^ top of page)
Meningitis - Symptom Check List
Meningitis and Septicaemia
Meningococcal Immunisation
Meningococcal Infection
Temperatures (Fevers) in ChildrenPatient Support related to this topic (^ top of page)
Meningitis Research Foundation
Meningitis Trust
Meningitis UKMedical reference articles in PatientPlus related to this topic (^ top of page)
Cerebrospinal Fluid
Meningitis
Meningococcal Disease (Neisseria Meningiditis)
Meningococcal VaccinesUK guidelines related to this topic (^ top of page)
Guidelines on Meningitis
Guidelines on Meningococcal InfectionOnline videos related to this topic (^ top of page)
Online videos on MeningitisRecent news items related to this topic (^ top of page)
Meningitis C deaths cut to zero
Meningitis B trials 'encouraging'
Fresh bid to cut deaths by meningitis in Scotland
Teen-jab theory over meningitis C
Fears over meningitis superbug strains
Obesity link to rise in diabetes
Vaccine resistant meningitis C
Pneumococcal bug poses new threat
Meningitis B trials 'encouraging'
Teen-jab theory over meningitis C
Fears over meningitis superbug strains
Obesity link to rise in diabetes
Vaccine resistant meningitis CLinks to other selected websites related to this topic (^ top of page)
Meningitis
Meningococcal InfectionOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
*** NEW *** Patient UK Newspaper
Meningitis news
Meningococcal Vaccines newsMedical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)


Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

